Sado et al. investigated the IRE1α-XBP1 pathway in a mouse model, demonstrating that the exogenous expression of XBP1 protected dopamine neurons from cell death induced by a range of molecules used to mimic PD pathology and suggested that enhancement of XBP1 represents a potential therapeutic strategy [26]. Here, XBP1 is linked to Parkinson disease.